ProfileGDS5678 / 1449847_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 9% 9% 9% 10% 10% 8% 14% 9% 10% 10% 9% 9% 13% 9% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.230259
GSM967853U87-EV human glioblastoma xenograft - Control 22.224349
GSM967854U87-EV human glioblastoma xenograft - Control 32.225969
GSM967855U87-EV human glioblastoma xenograft - Control 42.2095410
GSM967856U87-EV human glioblastoma xenograft - Control 52.2094810
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.246898
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3832114
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.203849
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2173610
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2269110
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.216899
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.208879
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3120713
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.223759